Patient Access Solutions Inc (PASO)

[TarheelBuyer]

PASO FULL DD PACKAGE

Quick Summary of the basics as follows:

PASO A/S 750,000,000

PASO O/S 541,791,244

PASO Tradable Float 146,425,869 as of 03/06/2020

PASO is already a complete debt free public vehicle with no 3rd party convertible noteholders involved whatsoever, that’s already generating positive net income. In other words, 1 of the cleanest OTC public vehicles for any mega-merging entity to consider merging into!

-Way back on August 20th, 2019 Hestia Investments put their own PR out specifically naming PASO as their very 1st Healthcare Hedge fund client:

https://www.hestiainsight.com/index.php/news

Then on December 16th, 2019 CEO Bruce Weitzberg agreed to cancel back to the PASO treasury his 10M control block preferred shares as follows:



PS: Nevada SOS is using a new portal called SilverFlume, and they’re extremely backlogged. But the moment the preferred cancellation is being properly reflected on Nevada SOS it will be posted here on ihub for everyone to view!

Then former PASO CEO Bruce Weitzberg filed his resignation letter on December 31st, 2019:

https://backend.otcmarkets.com/otcapi/company/financial-report/238354/content

PASO then put out a Press Release February 13th 2020, outlining their pending mega-merger entity that’s already being backed/supported by a $50B Wall Street fund via non-dilutive financing as outlined in the PR below:

https://backend.otcmarkets.com/otcapi/company/financial-report/238354/content

On the exact same day as the above PR, PASO put out the accompanying tweets to the above PR, proving that the pending mega-merging entity is already receiving non-dilutive financing from the soon to be unveiled Wall Street Fund as follows:



Meanwhile over the past several weeks Alpine exited their entire PASO position by sending out a sneaky paragraph on page 4 of their clients year end statements, that supposedly granted Alpine the authority to liquidate all PASO shareholder positions, unless said Alpine PASO shareholders contacted them by/b4 January 6th, 2019.

Alpine has been pulling this client liquidation tricks game on multiple clients across multiple OTC tickers, and has already been busted by the SEC for their shoddy SARS reporting requirements. And there’s already an active class action lawsuit against Alpine launched by shareholders from other OTC tickers Alpine did the same dirty trick on as easily verifiable in 1 of the links below that tells/presents the entire reason Alpine’s on the run in the 1st place including re-domiciling in Bermuda prior to end of year 2019 like that’s gonna help them with their phony baloney getaway plan!

The only reason this is being included in the PASO Due Diligence summary is to explain how a company (PASO), with no noteholders and no aged debt period, and already generating positive net income could even endure several weeks of T Trades that finally ended about 10 days ago when Alpine finally ran out of the PASO shareholder shares they were holding.

And here’s just 1 proven class action lawsuit that’s actively being pursued against Alpine on behalf of more and more OTC investors, when they unfortunately discover to their chagrin that Alpine screwed them out of their shares on multiple OTC positions not just PASO. With the funniest part being, every passing month more and more burnt Alpine shareholders will continue joining similar class action lawsuits that are rightfully being brought against Alpine for foolishly embarking on such a scheme after Alpine’s already been busted by the SEC for their shoddy SARS reporting requirements. The entire reason/result of Alpine liquidating completely unaware PASO shareholder positions along with all the other OTC PubCo liquidating that’s been going on for several quarters across the entire OTC, is that PASO’s float has increased to approximately 146M shares, 15M shares of which were just issued to a direct PASO affiliate(Dr. Lilazapone who leases the space for PASO’s Wellness Center). So, although those shares are counted in the float, they obviously have not been sold into the float.

Here’s an example of the entire Alpine mess and just 1 of the class action lawsuits currently underway against Alpine from other OTC investors who Alpine worked over, including their initial SARS violations that have had Alpine on the run in the 1st place:

Alpine Securities Corp
Alpine (a broker/dealer owned by John Hurry) was named in an SEC Complaint on June 15, 2017. According to the SEC, Alpine’s actions “made a mockery” of the system that is designed to catch suspicious financial activity. The number of violations, in the thousands, shows that Alpine’s actions were no mistake, the SEC claims. Although the SEC did not name the stocks involved, an entity related to Alpine called Scottsdale Capital Advisors Corp previously received a $1.5-million fine in connection with three companies, Neuro-Hitech, Inc. (NHPI), VoipPal.com (VPLM), and Orofino Gold Corp. (ORFG) – (see the Complaint). Also fined in that case were John Hurry, Timothy DiBlasi, and D Michael Cruz. Scottsdale has a history of being cited in share selling schemes. Scottsdale was cited in SEC litigation involving Rudi Nutrition Inc (RUNU), in litigation for the Biozoom (BIZM) scam and in SEC litigation against several offshore entities that were involved in pump & dump/share selling schemes run on SwingPlane Ventures Inc (SWVI), Goff Inc (GOFF), Nostra Energy Inc (NORX), and Xumanii Inc (XUII). According to the SEC, most of Alpine’s business comes from Scottsdale, and both firms are owned by the same man, John Joseph Hurry. The SEC is seeking $10,000 for each deficient SAR Violation by Alpine and $1,000 for each Document Retention Violation committed by Alpine for a total of $22,736,000. Alpine has been disputing the allegations.

https://www.sec.gov/litigation/complaints/2017/comp-pr2017-112.pdf

https://blogs.orrick.com/securities-litigation/tag/sec-v-alpine-securities-corp/

https://www.lexology.com/library/detail.aspx?g=8c2a9a03-b7f6-4e6b-beb3-8a92bc046a55

https://www.sec.gov/litigation/opinions/2019/34-87599.pdf

https://en.finance.sia-partners.com/20200207/deficient-suspicious-activity-reporting-rare-court-decision-broker-dealer-defficient-sar

And despite the illegial Alpine T Trade sell off, 2 PASO directors have recently been buying significant amounts of shares on the open market, which can be easily verified by viewing their open market disclosure links on OTC Markets as follows(which includes 2 more fresh filings today 3-10-2020 & PASO didn’t even BOTHER tweeting to promote the buys..THIS IS REAL):

There are multiple reasons insiders can have to sell insider/affiliate shares, but there’s only 1 reason for insider/affiliates to buy open market shares, and that’s solely because they firmly believe the share price of the PubCo they’re directors are in is going up!

ATTENTION: There’s absolutely ZERO rumor mill out there on who the merging entity it, what the fully audited valuation metrics of the merging entity will soon fully reflect, nor who the $50B Wall Street fund that’s already non-dilutive financing is!

And unlike 99% of OTC mergers out there that always get rumor milled, only to find out that it’s just some $30M CBD Company or something similarly very under-whelming.

The fact is that it’s an extremely rare occurrence when a $50B beyond well-established Wall Street fund is even remotely involved in any pending OTC mega-merger. So for all those SMART investors out there trying to connect all the ever-evolving/emerging value-driving elements of this extremely humungous jigsaw puzzle, we may just have ourselves 1 of the most amazing OTC mega-mergers of the past 2 to 3 decades! THIS IS REAL

And it can’t be overlooked that PASO also already recently informed us that after the merger filing ahead gets filed, they’re also going to be releasing the news on an international basis. Which means PASO is willing to spend approximately $10,000.00 to release an international PR, which clearly sends the strongest message possible that this is the furthest thing imaginable from your garden variety OTC merger! As few if any OTC mergers ever spend that kind of money to ensure their merger filing gets the international exposure/attention it deserves. And when the fully audited valuation metrics do become publicly known, it’s the $50B Wall Street analysts who are going to be taking this to their own global accredited investors.

THIS IS A NO BRAINER